Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 10, 2026 · Other material event · Financial statements
InMed Pharmaceuticals Inc.
10
Other material event
Jun 10, 2026
| Item 8.01 | Other events the company considers material |
| Item 9.01 | Financial statements and exhibits |
InMed Pharmaceuticals Inc. filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. 1 NASDAQ: INM Suite 1445-885 West Georgia St. com InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements Vancouver, BC - June 4, 2026 - InMed Pharmaceuticals Inc.
This filing reports Item 8.01 (other events the company considers material). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
InMed Pharmaceuticals Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
